Laboratory Test Preparation

| Test | : | Immunoflourescence IgA |
| Other Test Request Name | : | Immunoglobulin A
|
| Test Composition | : | Not Applicable |
| Intended Use | : | Increased IgA is associated with monoclonal IgA myeloma, respiratory and gastrointestinal infections, and malabsorption; decreased IgA is found in selective IgA deficiency and in ataxia telangiectasia.
|
| Methodology | : | Immunoturbidimetric
|
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation. |
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 72 Hours |
| • Refrigerated Temperature (2-8°C) | : | 7 days |
| • Freezer Temperature (-20°C) | : | 90 days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday 4:00 PM |
| TAT/Releasing of Results | : | 14 working days after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Not Applicable |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Not Applicable |
| Test | : | Immunoglobulin A/IgA |
| Other Test Request Name | : |
|
| Test Composition | : | Not applicable |
| Intended Use | : | Measures antibody levels or evaluates the effectiveness of treatment. One of the five classes of immunoglobulins; one of the most common immunoglobulins, it is mainly present in body secretions and is the chief antibody in the mucous membranes of the gastrointestinal and respiratory tract and in saliva and tears. |
| Methodology | : | Immnoturbidimetry |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 24 Hours |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | Not Applicable |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Monday and Thursday |
| Cut Off Time | : |
|
| TAT/Releasing of Results | : | 3 days after running day (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Not Applicable |
| Limitations/Interferences | : | None specified |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Total Immunoglobulins, Immunoglobulin G, IgG, Immunoglobulin M, IgM, Immunoglobulins, Quantitative |
| Test | : | Immunoglobulin G/IgG |
| Other Test Request Name | : |
|
| Test Composition | : | Not applicable |
| Intended Use | : | Measures antibody levels or evaluates the effectiveness of treatment. One of the five classes of immunoglobulins; one of the most common immunoglobulins, it is mainly present in body secretions and is the chief antibody in the mucous membranes of the gastrointestinal and respiratory tract and in saliva and tears. |
| Methodology | : | Immnoturbidimetry |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 24 Hours |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | Not Applicable |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Monday and Thursday |
| Cut Off Time | : |
|
| TAT/Releasing of Results | : | 3 days after running day (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Not Applicable |
| Limitations/Interferences | : | None specified |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Total Immunoglobulins, Immunoglobulin A, IgA, Immunoglobulin M, IgM, Immunoglobulins, Quantitative |
| Test | : | Immunoglobulin M/ IgM | |
| Other Test Request Name | : |
| |
| Test Composition | : | Not applicable | |
| Intended Use | : | Measures antibody levels or evaluates the effectiveness of treatment. One of the five classes of immunoglobulins; one of the most common immunoglobulins, it is mainly present in body secretions and is the chief antibody in the mucous membranes of the gastrointestinal and respiratory tract and in saliva and tears. | |
| Methodology | : | Immnoturbidimetry | |
| Laboratory Section | : | Special Test | |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. | |
| Collection/Sample Container | : | Red or Gold Tube | |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum | |
| Alternative Specimen and Volume Requirement | : | Not applicable | |
| Specimen Stability | |||
| • Room Temperature (15-25°C) | : |
| |
| • Refrigerated Temperature (2-8°C) | : | 7 Days | |
| • Freezer Temperature (-20°C) | : | Not Applicable | |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) | |
| Rejection Criteria | : |
| |
| Running Day | : | Monday and Thursday | |
| Cut Off Time | : |
| |
| TAT/Releasing of Results | : | 3 days after running day (excluding Saturdays, Sundays and Holidays) | |
| Reference Interval/Result Interpretation | : | Available upon request | |
| Limitations/Interferences | : | None specified | |
| Frequently Asked Questions (FAQs) | : | Not applicable | |
| Related Words/Test | : | Total Immunoglobulins, Immunoglobulin A, IgA, Immunoglobulin G, IgG, Immunoglobulins, Quantitative |
| Test | : | Immunotyping Electro (Urine) (BY APPOINTMENT PER PATIENT) |
| Other Test Request Name | : | Not Applicable |
| Test Composition | : | With Urine Total Potein |
| Intended Use | : | Immunofixation of urine is useful in evaluation of monoclonal free light chains and other monoclonal gammopathies seen in light chain disease, multiple myeloma, Waldenstrom's macroglobulinemia, amyloidosis, and other lymphoproliferative disorders. Increased polyclonal free light chains in urine may be seen in glomerular leak syndromes and in infection or inflammation. |
| Methodology | : | Immunofixation |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
NOTE: Do not collect specimen without approval of Special Test Section
Collection Procedures :
|
| Collection/Sample Container | : | Plastic leak proof clean container without preservative |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 100 mL of 24 hour Urine |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 24 Hours |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | 28 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Mondays and Thursdays |
| Cut Off Time | : | Thursday, 7:00 AM (Monday Running) Monday, 7:00 AM (Thursday Running) |
| TAT/Releasing of Results | : | 7 working days after running day (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None Specified. |
| Frequently Asked Questions (FAQs) | : | Not Applicable |
| Related Words/Test | : | Levels of certain proteins, monoclonal immunoglobulins, multiple myeloma, Waldenstrom macroglobulinemia. |
| Test | : | India Ink |
| Other Test Request Name | : | India Ink (Colloidal Carbon) Stain |
| Test Composition | : | Not applicable |
| Intended Use | : | India Ink is used to detect cryptococcal meningitis. This is also requested for immunocompromised patients such as those with AIDS, disseminated infection or debilitating diseases. Test should be done even without prior request if yeast cells are seen when performing a cell count or Gram stain |
| Methodology | : | Direct Microscopic Examination using Nigrosin stain |
| Laboratory Section | : | Bacteriology |
| Special Instructions/Patient Preparations | : | Instructions to Send-in Clients: • Indicate patient’s diagnosis, medical history and sample type on request forms. |
| Collection/Sample Container | : | Sterile leak-proof container |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 1 - 4 mL Cerebrospinal Fluid |
| Alternative Specimen and Volume Requirement | : | Not applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 6 Hours |
| • Refrigerated Temperature (2-8°C) | : | Not applicable |
| • Freezer Temperature (-20°C) | : | Not applicable |
| Transport Temperature | : | Transport specimens immediately (within 6 hours) to HPD Laboratory at room temperature (15-25°C) NOTE: Do not delay transport of samples. |
| Rejection Criteria | : | • Incorrect label • Quantity not sufficient • Exceeded sample stability and storage requirement |
| Running Day | : | Daily |
| Cut Off Time | : | 6:00 PM |
| TAT/Releasing of Results | : | ROUTINE: • 4 hours after receipt of specimen/ arrival of messenger STAT: • 1½ hours from extraction/messenger arrival |
| Reference Interval/Result Interpretation | : | Not applicable |
| Limitations/Interferences | : | India ink is limited to Cerebrospinal fluid (CSF) specimens only. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Not applicable |
| Test | : | Influenza A & B Ab (CF) |
| Other Test Request Name | : | Influenza A and B Antibodies
|
| Test Composition | : | Not Applicable |
| Intended Use | : | Influenza Type A and B viruses cause seasonal outbreaks of the flu. Both Type A and B are included in the flu vaccine. |
| Methodology | : | Complement Fixation (CF) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 24 Hours |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | 30 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Batch Running |
| Cut Off Time | : | Monday, 12:00 PM
|
| TAT/Releasing of Results | : | 2 weeks after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None Specified. |
| Frequently Asked Questions (FAQs) | : | Not Applicable |
| Related Words/Test | : | Flu Test, Rapid Flu Test, Influenza Antigen Test, H1N1, Rapid Influenza Diagnostic Test, RIDT, Flu PCR, Influenza Rapid Antigen Test, Influenza Type A and B Antigen Detection, Influenza A and B Culture, Influenza Type A H1N1, PCR for Influenza Virus |
| Test | : | Inhibin B (EIA) |
| Other Test Request Name | : | INH-B |
| Test Composition | : | Not applicable |
| Intended Use | : | Inhibin B is the major circulating inhibin in males. It is also detectable in women during menstrual cycles, particularly prior to ovulation. The measurement of inhibin B serves as an endocrine marker for monitoring male and female gonadal function. |
| Methodology | : | Enzyme Immunoassay (EIA) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 72 Hours |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | 28 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen • Markedly lipemic specimen • Exceeded sample stability requirement • Quantity not sufficient • Improperly labeled specimen • Improper collection tube used |
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday 4:00 PM |
| TAT/Releasing of Results | : | 2 weeks after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Spermatogenesis function and male infertility |
| Test | : | Insulin (ECLIA) |
| Other Test Request Name | : | • Serum Insulin |
| Test Composition | : | Not applicable |
| Intended Use | : | The determination of insulin is utilized in the diagnosis and therapy of various disorders of carbohydrate metabolism, including diabetes mellitus and hypoglycemia. |
| Methodology | : | Electrochemiluminescence Immunoassay (ECLIA) |
| Laboratory Section | : | Immunology |
| Special Instructions/Patient Preparations | : | • Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration. |
| Collection/Sample Container | : | Red or Gold tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 1-3 mL Serum |
| Alternative Specimen and Volume Requirement | : | 1-3 mL Plasma (Li?heparin, K3 ?EDTA and Sodium Citrate) |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | Not specified |
| • Refrigerated Temperature (2-8°C) | : | 24 Hours |
| • Freezer Temperature (-20°C) | : | 6 Months (Freeze only once) |
| Transport Temperature | : | Transport specimen at 2°C – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen (Hemolysis interferes, as insulin?degrading peptidases are released from |
| Running Day | : | Monday, Wednesday, Friday |
| Cut Off Time | : | Monday to Saturday:10:00 PM Sunday:6:00PM |
| TAT/Releasing of Results | : | ROUTINE (on running days) |
| Reference Interval/Result Interpretation | : | 2.60-24.90 uU/mL |
| Limitations/Interferences | : | • Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | C-peptide, Glucose Tests |
| Test | : | Insulin (HOMA) |
| Other Test Request Name | : |
|
| Test Composition | : | Not Applicable |
| Intended Use | : | Differential diagnosis of diabetes and investigation of pancreatic function. |
| Methodology | : | Electrochemiluminescence |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : |
RECEPTION/ENCODERS:
? TEST CODE: HOMA9 - Insulin (HOMA) paired with FBS - FBS (HEXOKINASE)
BRANCHES:
|
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 24 Hours |
| • Refrigerated Temperature (2-8°C) | : | 5 Days |
| • Freezer Temperature (-20°C) | : | 1 Month |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : |
|
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday, 12:00 PM
|
| TAT/Releasing of Results | : | 2 weeks after cut off (excluding saturday, sunday and holidays) |
| Reference Interval/Result Interpretation | : | Available Upon Request
|
| Limitations/Interferences | : | Interference possible in patients treated with biotin (vitamin B7, B8 or H) or taking any food supplements containing biotin.
|
| Frequently Asked Questions (FAQs) | : | Q: What is insulin resistance? A:Insulin resistance is classically defined as impaired whole-body insulin-mediated glucose disposal. However, defective insulin action is not confined to impaired glucose disposal; it can also be seen in protein and fat metabolism. Therefore, a more accurate definition of insulin resistance is “a state in which normal insulin levels produce an attenuated biological response. “Improvement of insulin sensitivity/insulin action or reduction in insulin resistance, as a therapeutic principle may play a central role in the primary prevention and treatment of type 2 diabetes, hypertension, and atherosclerosis. Q: How common is insulin resistance? A:Insulin resistance is very common in the general population. The prevalence of insulin resistance has been estimated to be as high as 88% in people with lipid abnormalities, such as elevated triglycerides and low HDL. Considering that over half of all adults in Western populations have lipid abnormalities; it becomes clear that insulin resistance is not a problem confined to diabetes but a mass problem afflicting the vast majority. A surprising finding is that people with elevated triglycerides and low HDL can have a similar degree of insulin resistance as that seen in patients with type 2 diabetes. Importantly, in the general population insulin resistance can be found even in the absence of any major metabolic disorders, and 25% of apparently healthy people are severely insulin resistant. This can be detected by elevated fasting insulin and glucose levels and the HOMA-IR index and may be an indicator of “silent” atherosclerosis. Q: What is the value of assessing insulin resistance? A:Insulin resistance is an independent risk factor for all-cause and cardiovascular mortality, and multiple studies have shown that insulin resistance is a strong predictor of atherosclerotic cardiovascular disease as well as adverse cardiovascular outcomes in both non-diabetic and diabetic individuals. A notable study found that insulin resistance, as estimated by HOMA-IR was associated with incident symptomatic cardiovascular disease after a 15-year follow-up. Importantly, the association of insulin resistance with cardiovascular disease was independent of classic risk factors (including hyperglycemia, hypertension, high LDL cholesterol, smoking, and physical activity) and of other components of the metabolic syndrome (obesity, hypertriglyceridemia, and low HDL cholesterol).
|
| Related Words/Test | : | Insulinaemia, Insulin, Fasting Blood Sugar
|
| Test | : | Insulin (RIA) Temporarily Unavailable (currently not accepting samples) |
| Other Test Request Name | : | Not applicable |
| Test Composition | : | Not applicable |
| Intended Use | : | • Diagnosis of insulinoma and other causes of hypoglycemia |
| Methodology | : | Radio Immuno Assay (RIA) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 72 Hours |
| • Refrigerated Temperature (2-8°C) | : | 7 Days |
| • Freezer Temperature (-20°C) | : | 28 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Wednesday 8:00 AM |
| Cut Off Time | : | Tuesday 4:00 PM |
| TAT/Releasing of Results | : | After 3 days (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Fasting Insulin, Insulin, serum |
| Test | : | Insulin Ab (Free & Total) |
| Other Test Request Name | : |
|
| Test Composition | : | • Total Insulin • Free Insulin |
| Intended Use | : | Can appear in insulin-dependent diabetics being treated with insulin.
|
| Methodology | : | Radioimmunoassay |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 3 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 28 days |
| • Refrigerated Temperature (2-8°C) | : | 28 days |
| • Freezer Temperature (-20°C) | : | 28 days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday 4:00 PM |
| TAT/Releasing of Results | : | 14 working days after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Not Applicable |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Not Applicable |
| Test | : | Insulin Growth Factor 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Test Request Name | : |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Test Composition | : | Not Applicable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Intended Use | : | • This test measures the amount of insulin-like growth factor – 1 in blood. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Methodology | : | Enzyme-linked Immunosorbent Assay (ELISA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Laboratory Section | : | Serology | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special Instructions/Patient Preparations | : | No patient preparation necessary. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Collection/Sample Container | : | Red or Gold tube | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 1-2mL Serum Note: Separate serum immediately. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative Specimen and Volume Requirement | : | Not Applicable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Specimen Stability | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| • Room Temperature (15-25°C) | : | Not Specified | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| • Refrigerated Temperature (2-8°C) | : | 24 hours | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| • Freezer Temperature (-20°C) | : |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transport Temperature | : | Transport specimen at 2 – 10 °C (with cold packs) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Rejection Criteria | : |
• Lipemic specimens • Icteric specimens • Samples containing sodium azide | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Running Day | : | Monday (Batch running) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cut Off Time | : | Sunday, 5:00 PM | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TAT/Releasing of Results | : | Tuesday, 9:00AM | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reference Interval/Result Interpretation | : |
Reference: Demeditec IGF-I 600 ELISA DE4140 Version 10 - 06/18 JS (Updated 180628) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Limitations/Interferences | : | • Bacterial contamination or heat inactivation of the specimens may affect the test results. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Frequently Asked Questions (FAQs) | : | Not Applicable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Related Words/Test | : | Growth Hormone, Somatomedin C |
| Test | : | Insulin Growth Factor BP3 |
| Other Test Request Name | : | • IgFBP3 • Insulin-Like Growth Factor Binding Protein |
| Test Composition | : | Not applicable |
| Intended Use | : | • IGFBP-3 is growth hormone (GH) responsive. Thus, levels are high in acromegaly and low in hypopituitarism, and levels increase in GH-deficient children after GH administration. Other causes of short stature that result in reduced IGFBP-3 levels include poorly controlled diabetes. • The IGFBP-3 assay is useful in assessing nutritional status, since IGFBP-3 decreases during both caloric and protein restriction. |
| Methodology | : | Immunoassay (IA) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | Red or Gold Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 2 mL Serum |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 7 Days |
| • Refrigerated Temperature (2-8°C) | : | 14 Days |
| • Freezer Temperature (-20°C) | : | 1 Year |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen |
| Running Day | : | Batch Running |
| Cut Off Time | : | Monday, 12:00 PM
|
| TAT/Releasing of Results | : | 2 weeks after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Applicable upon request. |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Growth Hormone, Somatomedin C, IGF1 |
| Test | : | Interleukin 1 Beta (EIA) |
| Other Test Request Name | : | IL-1 |
| Test Composition | : | Not applicable |
| Intended Use | : | Interleukin 1-beta (IL-1 beta) is a paracrine cytokine. High levels are observed in septic shock. This cytokine is involved in the pathogenesis of rheumatoid arthritis and, in patients with this condition, its concentration in synovial fluid is significantly increased but not its serum concentration. |
| Methodology | : | Enzyme Immunoassay (EIA) |
| Laboratory Section | : | Special Test |
| Special Instructions/Patient Preparations | : | No patient preparation necessary. |
| Collection/Sample Container | : | EDTA or Violet Tube |
| Specimen and Volume Requirement Note:Follow tube manufacturer recommendation. | : | 4 mL Plasma |
| Alternative Specimen and Volume Requirement | : | Not Applicable |
| Specimen Stability | ||
| • Room Temperature (15-25°C) | : | 24 Hours |
| • Refrigerated Temperature (2-8°C) | : | 48 Hours |
| • Freezer Temperature (-20°C) | : | 21 Days |
| Transport Temperature | : | Transport specimen at 2 – 8 °C (with cold packs) |
| Rejection Criteria | : | • Hemolyzed specimen • Markedly lipemic specimen • Exceeded sample stability requirement • Quantity not sufficient • Improperly labeled specimen • Improper collection tube used • Clotted specimen • Over-filled or Under-filled tube |
| Running Day | : | Batch Running |
| Cut Off Time | : | Friday 4:00 PM |
| TAT/Releasing of Results | : | 1 month after cut-off (excluding Saturdays, Sundays and Holidays) |
| Reference Interval/Result Interpretation | : | Available upon request |
| Limitations/Interferences | : | None specified. |
| Frequently Asked Questions (FAQs) | : | Not applicable |
| Related Words/Test | : | Leukocytic pyrogen, leukocytic endogenous mediator, mononuclear cell factor, lymphocyte activating factor, cytokine protein |